Smith BioTech was founded with a clear vision: to make peptide research more transparent, compliant, and innovative. We believe peptides are a powerful frontier in advancing human health — but the lack of public data, compound stability, half-life control, variety of peptide synthesis and bonding techniques and verified studies has hindered the progression of large scale adoption.

By documenting best practices, delivering high-purity materials, ensuring rigorous quality standards, and introducing AI-driven insights, we’re changing how the world approaches peptide discovery. Our work enables research teams to move faster, ask bigger questions, and unlock new possibilities in longevity and beyond.